StockData
Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc. (ARCT) income statement

ARCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3014% below fair value
$7.45−0.15 (-1.97%)

Close on Nov 20, 2026Market cap $211.75MP/E –Yield –

Arcturus Therapeutics Holdings Inc. financial ratios

See a number that looks wrong?